These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 17942945

  • 1. Interferon-beta: a novel way to treat nephrotic syndrome?
    Rees AJ, Kain R.
    J Am Soc Nephrol; 2007 Nov; 18(11):2797-8. PubMed ID: 17942945
    [No Abstract] [Full Text] [Related]

  • 2. Levamisole therapy in nephrotic syndrome.
    Srivastava RN.
    Pediatr Nephrol; 1999 Sep; 13(7):636. PubMed ID: 10507834
    [No Abstract] [Full Text] [Related]

  • 3. Protracted levamisole in children with frequent-relapse nephrotic syndrome.
    Ginevri F, Trivelli A, Ciardi MR, Ghiggeri GM, Parfumo F, Gusmano R.
    Pediatr Nephrol; 1996 Aug; 10(4):550. PubMed ID: 8865269
    [No Abstract] [Full Text] [Related]

  • 4. [The influence of betaserk and cinarizine on vestibular function, highest nervous activity and brain circulation in chronic cerebral ischemia: a model study].
    Grishina TR, Gromova OA, Sadin AV, Nazarenko OA, Zhidomorov NIu, Borzunov MP, Vatsuro AA, Nikonov AA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004 Aug; 104(2):61-3. PubMed ID: 15002324
    [No Abstract] [Full Text] [Related]

  • 5. Multiple sclerosis and systemic sclerosis: efficacy of interferon beta on skin lesions.
    Carrieri PB, Petracca M, Montella S, Delfino M, Sepe C, Gattoni A.
    Ann Rheum Dis; 2008 Aug; 67(8):1192-3. PubMed ID: 18621969
    [No Abstract] [Full Text] [Related]

  • 6. The treatment of multiple sclerosis with beta-interferon.
    Poser CM.
    Neuroepidemiology; 2008 Aug; 31(3):157-8. PubMed ID: 18716413
    [No Abstract] [Full Text] [Related]

  • 7. Biological response genes after single dose administration of interferon beta-1b to healthy male volunteers.
    Hilpert J, Beekman JM, Schwenke S, Kowal K, Bauer D, Lampe J, Sandbrink R, Heubach JF, Stürzebecher S, Reischl J.
    J Neuroimmunol; 2008 Aug 13; 199(1-2):115-25. PubMed ID: 18565596
    [Abstract] [Full Text] [Related]

  • 8. Comparison of methods of inducing experimental nephrotic syndrome in lab animals.
    Pedrycz A, Wieczorski M, Czerny K.
    Ann Univ Mariae Curie Sklodowska Med; 2003 Aug 13; 58(2):116-20. PubMed ID: 15323177
    [Abstract] [Full Text] [Related]

  • 9. [Levamisole in the treatment of nephrotic syndrome].
    García Soto L, Miranda Romera P, Vintimilla Andrade JE, Gómez Llorente MA, de Diego Fernández P.
    An Pediatr (Engl Ed); 2020 Mar 13; 92(3):168-169. PubMed ID: 31151760
    [No Abstract] [Full Text] [Related]

  • 10. Interferon beta-1a treatment of corticosteroid sensitive polymyositis.
    Dressel A, Beuche W.
    J Neurol Neurosurg Psychiatry; 2002 May 13; 72(5):676. PubMed ID: 11971067
    [No Abstract] [Full Text] [Related]

  • 11. Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a.
    Almeida L, Neves M, Cardoso E, Melo A.
    J Clin Pharm Ther; 2009 Feb 13; 34(1):125-7. PubMed ID: 19125911
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.
    Minagar A, Alexander JS, Schwendimann RN, Kelley RE, Gonzalez-Toledo E, Jimenez JJ, Mauro L, Jy W, Smith SJ.
    Arch Neurol; 2008 Feb 13; 65(2):199-204. PubMed ID: 18071030
    [Abstract] [Full Text] [Related]

  • 13. Is there a contraindication for polio vaccination in children who are treated with levamisole?
    Blanche S.
    Pediatr Nephrol; 2000 Sep 13; 14(10-11):1059. PubMed ID: 10975326
    [No Abstract] [Full Text] [Related]

  • 14. Use of interferon beta for acute respiratory distress syndrome: proceed with caution--authors' reply.
    Bellingan G, Montgomery H, Maksimow M, Salmi M, Jalkanen S.
    Lancet Respir Med; 2014 Apr 13; 2(4):e2-3. PubMed ID: 24717630
    [No Abstract] [Full Text] [Related]

  • 15. Interferon-beta1b in multiple sclerosis: effect on progression of disability and clinical markers of treatment response.
    Carmona O, Casado V, Moral E, Alonso-Magdalena L, Martínez-Yélamos A, Martínez-Yélamos S, Martín-Ozaeta G, Arbizu T.
    Eur Neurol; 2008 Apr 13; 60(6):279-84. PubMed ID: 18824855
    [Abstract] [Full Text] [Related]

  • 16. Spindle-cell sarcoma of the female breast.
    De Dycker RP, Schumacher T, Neumann RL.
    J Chemother; 1989 Jul 13; 1(4 Suppl):1251-3. PubMed ID: 16312854
    [No Abstract] [Full Text] [Related]

  • 17. Immunomodulating treatment in primary glomerulonephritides.
    Piccoli G, Quarello F, Basolo B, Roccatello D, Rollino C, Beltrame G, Piccoli GB.
    Pharmacol Res; 1992 Sep 13; 26 Suppl 2():112-3. PubMed ID: 1409268
    [No Abstract] [Full Text] [Related]

  • 18. Use of interferon beta for acute respiratory distress syndrome: proceed with caution.
    George PM, Wort SJ, Mitchell JA.
    Lancet Respir Med; 2014 Apr 13; 2(4):e2. PubMed ID: 24717629
    [No Abstract] [Full Text] [Related]

  • 19. Glatiramer acetate versus interferon beta-1a for subcutaneous administration: comparison of outcomes among multiple sclerosis patients.
    Castelli-Haley J, Oleen-Burkey M, Lage MJ, Johnson KP.
    Adv Ther; 2008 Jul 13; 25(7):658-73. PubMed ID: 18641926
    [Abstract] [Full Text] [Related]

  • 20. Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis.
    Farrell R, Bendtzen K, Bertolotto A, Clark B, Comabella M, Deisenhammer F, Fogdell-Hahn A, Giovannoni G, Hartung HP, Hemmer B, Hillert J, Kappos L, Killestein J, Lindberg R, Montalban X, Polman C, Sorensen PS, European NABINMS Consortium.
    J Int Med Res; 2008 Jul 13; 36(1):204-8; author reply 208-10. PubMed ID: 18230281
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.